Artificial intelligence-assisted colonoscopy
Artificial intelligence-assisted colonoscopy has been studied in 3 papers since 2026: 1 trial in people, 2 reviews; 3 in the past year. The newest paper, Oct 30, 2026: “Evolution of Colorectal Cancer Screening Technologies and Health Economic Evaluation: Optimization Strategies Based on an Economic Gradient and Dynamic Risk Stratification”.
3 papers study it3 findingsUpdated
2 new papers in 30 daysSee all 3
“ADR (61.5% with AI vs. 69.8% without AI, p = 0.097) and advanced colorectal neoplasia detection rate (37.9% vs. 36.3%, p = 0.753) did not differ significantly between groups.”
None of its findings points the other way.
- 1 lab in 1 country
- Human trial1
Studies in people
1 study gave artificial intelligence-assisted colonoscopy to people and measured what changed.
no change: Has no effect on adenoma detection rate61.5% vs 69.8%, p = 0.097
no change: Has no effect on advanced colorectal neoplasia detection rate37.9% vs 36.3%, p = 0.753
Randomized trial361 people50-74 years
Midlife adults; Older adults; FIT-positive colorectal cancer screening
Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland, Mar 1, 2026
What did studies of Artificial intelligence-assisted colonoscopy find?
3Studies of Artificial intelligence-assisted colonoscopy measured 3 outcomes; the most studied are Adenoma miss rate (1 study), advanced colorectal neoplasia detection rate (1) and adenoma detection rate (1).
Adenoma miss rate
downin humans1
1 study
Adenoma miss rate
downin humans1
Artificial intelligence-assisted colonoscopy decreases adenoma miss rate in humans (randomized tandem studies).
“artificial intelligence (AI)-assisted colonoscopy—specifically computer-aided detection (CADe), as distinct from computer-aided diagnosis (CADx)—reduces adenoma miss rates in randomized tandem studies”
Reviewrandomized tandem studiescomputer-aided detectioncolon
Frontiers in medicine
Advanced colorectal neoplasia detection rate
no changein humans1
1 study
Advanced colorectal neoplasia detection rate
no changein humans1
Artificial intelligence-assisted colonoscopy showed no clear effect on advanced colorectal neoplasia detection rate in humans (FIT-positive colorectal cancer screening) (37.9% vs 36.3%, p = 0.753).
“advanced colorectal neoplasia detection rate (37.9% vs. 36.3%, p = 0.753) did not differ significantly between groups”
Human trialFIT-positive colorectal cancer screeningn = 361
Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland
Adenoma detection rate
no changein humans1
1 study
Adenoma detection rate
no changein humans1
Artificial intelligence-assisted colonoscopy showed no clear effect on adenoma detection rate in humans (FIT-positive colorectal cancer screening) (61.5% vs 69.8%, p = 0.097).
“ADR (61.5% with AI vs. 69.8% without AI, p = 0.097) and advanced colorectal neoplasia detection rate (37.9% vs. 36.3%, p = 0.753) did not differ significantly between groups.”
Human trialFIT-positive colorectal cancer screeningn = 361
Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland